Familial
Showing 4276 - 4300 of 4,705
Purpura, Thrombotic Thrombocytopenic Trial (Octaplas infusion and (group 1), Octaplas infusion and (group 2))
Withdrawn
- Purpura, Thrombotic Thrombocytopenic
- Octaplas infusion and placebo (group 1)
- Octaplas infusion and placebo (group 2)
- (no location specified)
Dec 18, 2012
Atherosclerosis, Heterozygous Familial Hypercholesterolemia Trial in Worldwide (Pactimibe sulfate)
Terminated
- Atherosclerosis
- Heterozygous Familial Hypercholesterolemia
- Pactimibe sulfate
-
Santa Ana, California
- +36 more
Jan 16, 2012
Symptomatic Refractory Resistant Carcinoid Disease Trial in Worldwide (Pasireotide, Octreotide)
Completed
- Symptomatic Refractory Resistant Carcinoid Disease
-
Scottsdale, Arizona
- +61 more
Jun 25, 2013
Risk Factors for Venous Thromboembolism in the Community
Completed
- Cardiovascular Diseases
- Thromboembolism
-
Rochester, MinnesotaMayo Clinic
Dec 5, 2012
Hemoglobin SC Disease Trial in United States (Hydroxyurea, Magnesium Pidolate, Placebo Pills and Placebo Liquid)
Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))
Completed
- Chronic Myelogenous Leukemia
- imatinib mesilate
- +2 more
-
Birmingham, Alabama
- +162 more
Aug 7, 2013
Substance Use, Delinquency Trial in Miami (Multidimensional Family Therapy (MDFT), Adolescent Residential Treatment)
Completed
- Substance Use
- Delinquency
- Multidimensional Family Therapy (MDFT)
- Adolescent Residential Treatment
-
Miami, Florida
- +1 more
Nov 26, 2012
Ampullary Tumors Trial in Paris
Completed
- Ampullary Tumors
-
Paris, FranceSociété Française d'Endoscopie Digrestive
Mar 11, 2013
Drug Abuse Trial in Baltimore (Integrated Family and Cognitive-Behavioral Therapy, Education)
Completed
- Drug Abuse
- Integrated Family and Cognitive-Behavioral Therapy
- Education
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Sep 27, 2012
Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor Trial in Worldwide (Everolimus 10 mg, Octreotide Depot)
Completed
- Islet Cell Carcinoma
- +3 more
- Everolimus 10 mg
- Octreotide Depot
-
Birmingham, Alabama
- +53 more
May 6, 2013
Hepatitis B Trial in Worldwide (Entecavir (ETV), Adefovir (ADV))
Completed
- Hepatitis B
- Entecavir (ETV)
- Adefovir (ADV)
-
San Diego, California
- +60 more
Jun 17, 2013
Familial Cold Autoinflammatory Syndrome (FCAS), Familial Cold Urticaria, Muckle-Wells Syndrome (MWS) Trial in United States
Completed
- Familial Cold Autoinflammatory Syndrome (FCAS)
- +3 more
- rilonacept 160 mg
- Placebo
-
Little Rock, Arkansas
- +23 more
Dec 1, 2011
Raynaud Phenomenon Trial in Seoul (Udenafil or Amlodipine)
Completed
- Raynaud Phenomenon
- Udenafil or Amlodipine
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 7, 2012
Hypercholesterolemia Trial in Leiden (SPC5001, Saline 0.9%)
Terminated
- Hypercholesterolemia
- SPC5001
- Saline 0.9%
-
Leiden, NetherlandsCentre for Huma Drug Research (CHDR)
Nov 21, 2011
Attention Deficit Hyperactivity Disorder Youth Treated With
Completed
- ADHD
- Smoking
-
Cambridge, MassachusettsMassachusetts General Hospital
May 2, 2012
Carcinoma, Large Cell, NSCLC, Carcinoma, Squamous Cell Trial in Worldwide (CP 751,871 (Figitumumab), Erlotinib)
Terminated
- Carcinoma, Large Cell
- +3 more
- CP 751,871 (Figitumumab)
- Erlotinib
-
Fort Smith, Arkansas
- +174 more
Jul 22, 2013
Multidisciplinary Study of Right Ventricular Dysplasia
Completed
- Heart Diseases
- Arrhythmogenic Right Ventricular Dysplasia
-
Tucson, ArizonaUniversity of Arizona
Jan 15, 2013
Mood Disorders Trial in Cincinnati (quetiapine)
Completed
- Mood Disorders
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Jul 17, 2012
Liver Transplantation Trial in Worldwide (Tacrolimus (reduced tacrolimus), Tacrolimus (tacrolimus elimination), Tacrolimus
Completed
- Liver Transplantation
- Tacrolimus (reduced tacrolimus)
- +5 more
-
Los Angeles, California
- +90 more
May 17, 2013
Lamotrigine Pregnancy Registry (LAM05)
Completed
- Epilepsy
- Bipolar Disorder
- Lamotrigine monotherapy
- +2 more
- (no location specified)
Feb 21, 2013
Endocrine System Diseases Trial in Paris (Somatropin)
Terminated
- Endocrine System Diseases
-
Paris, FrancePfizer Investigational Site
Oct 26, 2012